These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11556278)

  • 1. Incremental validity of the Ego Impairment Index: a re-examination of Dawes (1999).
    Perry W
    Psychol Assess; 2001 Sep; 13(3):403-7. PubMed ID: 11556278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Let's call the whole thing off: a response to Dawes (2001).
    Perry W
    Psychol Assess; 2003 Dec; 15(4):582-5. PubMed ID: 14692852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinements in the Rorschach Ego Impairment Index incorporating the human representational variable.
    Viglione DJ; Perry W; Meyer G
    J Pers Assess; 2003 Oct; 81(2):149-56. PubMed ID: 12946921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental validity of the Ego Impairment Index: it's fine when it's there.
    Dawes RM
    Psychol Assess; 2001 Sep; 13(3):408-9. PubMed ID: 11556279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Meta-Analysis of the relationship between the Rorschach Ego Impairment Index (EII) and psychiatric severity.
    Diener MJ; Hilsenroth MJ; Shaffer SA; Sexton JE
    Clin Psychol Psychother; 2011; 18(6):464-85. PubMed ID: 20941796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ego Impairment Index and schizophrenia: a validation study.
    Perry W; Viglione D; Braff D
    J Pers Assess; 1992 Aug; 59(1):165-75. PubMed ID: 1512674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rorschach Ego Impairment Index in heterogeneous psychiatric patients.
    Adrian C; Kaser-Boyd N
    J Pers Assess; 1995 Dec; 65(3):408-14. PubMed ID: 8609582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of new and revised Rorschach measures of schizophrenic functioning in a Serbian clinical sample.
    Dzamonja-Ignjatovic T; Smith BL; Djuric Jocic D; Milanovic M
    J Pers Assess; 2013; 95(5):471-8. PubMed ID: 23844937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of the Ego Impairment Index across the schizophrenia spectrum.
    Perry W; Minassian A; Cadenhead K; Sprock J; Braff D
    J Pers Assess; 2003 Feb; 80(1):50-7. PubMed ID: 12584067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing disturbed thinking and cognition using the Ego Impairment Index in older schizophrenia patients: paranoid vs. nonparanoid distinction.
    Auslander LA; Perry W; Jeste DV
    Schizophr Res; 2002 Jan; 53(3):199-207. PubMed ID: 11738533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the Rorschach Ego Impairment Index and the Level of Personality Organization interview assessment in depressive and anxiety disorder patients.
    Valkonen H; Lindfors O; Knekt P
    Psychiatry Res; 2012 Dec; 200(2-3):849-56. PubMed ID: 22633010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rorschach Ego Impairment Index: prediction of treatment outcome in a child psychiatric population.
    Stokes JM; Pogge DL; Powell-Lunder J; Ward AW; Bilginer L; DeLuca VA
    J Pers Assess; 2003 Aug; 81(1):11-9. PubMed ID: 12842799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reality Testing in Children with Childhood-Onset Schizophrenia and Normal Children: A Comparison using the Ego Impairment Index on the Rorschach.
    Mohammadi MR; Hosseininasab A; Borjali A; Mazandarani AA
    Iran J Psychiatry; 2013 Mar; 8(1):44-50. PubMed ID: 23682251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental validity of the Rorschach Prognostic Rating Scale over the MMPI Ego Strength Scale and IQ.
    Meyer GJ
    J Pers Assess; 2000 Jun; 74(3):356-70. PubMed ID: 10900565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive validity of the Rorschach Prognostic Rating Scale with schizophrenic patients.
    Newmark CS; Konanc JT; Simpson M; Boren RB; Prillaman K
    J Nerv Ment Dis; 1979 Mar; 167(3):135-43. PubMed ID: 438781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ego Impairment Index (EII-2) as a predictor of outcome in short- and long-term psychotherapy during a 5-year follow-up.
    Stenius J; Heinonen E; Lindfors O; Holma J; Knekt P
    J Clin Psychol; 2022 Sep; 78(9):1739-1751. PubMed ID: 35226756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Ego Impairment Index as a predictor of outcome in melancholic depressed patients treated with tricyclic antidepressants.
    Perry W; Viglione DJ
    J Pers Assess; 1991 Jun; 56(3):487-501. PubMed ID: 1865307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Information-processing deficits and thought disorder in schizophrenia.
    Perry W; Braff DL
    Am J Psychiatry; 1994 Mar; 151(3):363-7. PubMed ID: 8109644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rorschach: facts, fictions, and future.
    Viglione DJ; Hilsenroth MJ
    Psychol Assess; 2001 Dec; 13(4):452-71. PubMed ID: 11793891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ego impairment and ego adaptation in schizophrenia.
    Kaplan ML
    J Proj Tech Pers Assess; 1967 Jun; 31(3):7-17. PubMed ID: 6061778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.